Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran-Reference-Cited by-同舟云学术

Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran

Published:2021-03-18 Issue: Volume: Page:
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Salehi-Vaziri Mostafa,Jalali Tahmineh,Farahmand Behrokh,Fotouhi Fatemeh,Banifazl Mohammad,Pouriayevali Mohammad Hassan,Sadat Larijani Mona,Afzali Neda,Ramezani Amitis^ORCID

Funder

Pasteur Institute of Iran

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10096-021-04221-6.pdf

Reference39 articles.

1. Epaulard O, Adam L, Poux C et al (2014) Macrophage- and neutrophil-derived TNF-alpha instructs skin langerhans cells to prime antiviral immune responses. J Immunol (Baltimore, Md : 1950) 193(5):2416–2426

2. Hung IF-N, Cheng VC-C, Li X et al (2020) SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series. Lancet Infect Dis 20(9):1051–1060

3. Sewell HF, Agius RM, Stewart M et al (2020) Cellular immune responses to covid-19. BMJ 370:m3018

4. Changes in antibodies and RNA shedding during early SARS-CoV-2 infection [press release]. News Medicla Life Science, May 22, 2020 2020.

5. Udugama B, Kadhiresan P, Kozlowski HN et al (2020) Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano 14(4):3822–3835

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons from COVID-19 Pandemic: A Successful Policy and Practice by Pasteur Institute of Iran;Iranian Biomedical Journal;2024-01-01

2. A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports;European Journal of Medical Research;2023-11-26

3. Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals;PLOS Pathogens;2023-11-01

4. Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine;Heliyon;2023-10

5. PastoCovac and PastoCovac Plus as protein subunit COVID-19 vaccines led to great humoral immune responses in BBIP-CorV immunized individuals;Scientific Reports;2023-05-18